Drug
Ozenoxacin
Ozenoxacin: highest development phase Phase 3, developed by Ferrer. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Ferrer
Trials
| Drug | Phase | Indication |
|---|---|---|
| Ozenoxacin NCT02090764 | Phase 3 | Impetigo |
Latest
No recent events.
Follow Ozenoxacin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.